Publications by authors named "Prerana P"
Maxillofacial Injury Patterns in Road Traffic Accidents- Clinical and Radiological Evaluation.
Indian J Otolaryngol Head Neck Surg
December 2024
To know the clinical signs and radiological findings of different types of maxillofacial fractures following facial trauma in road traffic accidents. In this retrospective study, the medical records and computerized tomography scans of 100 patients who have sustained facial fractures in road traffic accident during 2021-2022 were reviewed at Raichur Institute of Medical Sciences, Raichur; for maxillofacial fractures. Data was tabulated and statistically analysed using SPSS software version 21.
View Article and Find Full Text PDFTo study the presentation and plan of treatment of patient with Rosai Dorfman Disease. Rosai-Dorfman disease(RDD), is rare, non-neoplastic, multisystemic histiocytic disorder. Nodal form is more common.
View Article and Find Full Text PDFNasal Microbiota and Sensitivity Pattern in Rhinosinusitis.
Indian J Otolaryngol Head Neck Surg
February 2024
Article Synopsis
- The study aims to identify the microorganisms causing rhinosinusitis and examine the antibiotic sensitivity patterns of nasal microbiota in a specific region.
- Rhinosinusitis is an inflammatory condition influenced by various microorganisms, and despite frequent antibiotic use, sensitivity-based prescribing is uncommon.
- The research involved collecting nasal swabs from 100 patients diagnosed with rhinosinusitis, revealing that Klebsiella and Staphylococcus aureus were the most common pathogens, with specific sensitivities to beta lactams and quinolones, highlighting the importance of targeted antibiotic use to combat resistance.
Oxidation-reduction reactions played a significant role in the chemical evolution of life forms on oxygenated earth. Cellular respiration is dependent on such redox reactions, and any imbalance leads to the accumulation of reactive oxygen species (ROS), resulting in both chronic and acute illnesses. According to the International Agency for Research on Cancer (IARC), by 2040, the global burden of new cancer cases is expected to be around 27.
View Article and Find Full Text PDF